To Get Help Now
Click Here
Today's Date:

Judge Allows Bayer To Depose First 100 Plaintiffs In Yaz, Yasmin, Ocella MDL

AddThis Social Bookmark Button

After Bayer compared fact sheets filed by plaintiff attorneys against deposition testimony of 24 plaintiffs and found problems with more than one third of them, U.S. District Judge David Herndon ruled that Bayer can depose the first 100 plaintiffs of thousands to compare fact sheets and testimony against oral contraceptives Yaz, Yasmin, and their generic equivalent Ocella, alleging the drugs harm the gall bladder and cause circulation problems.

Judge Herndon wrote “In one case, the revisions were reportedly so extensive as to involve identification of additional treating physicians, changes in dates of treatment and hospital admissions, identification of additional pharmacies, identification of additional medical conditions and medications, and new information regarding the use of oral contraceptives.”
“In another case, the plaintiff allegedly misidentified the prescriber of her Yaz prescription on the plaintiff fact sheet and failed to identify the pharmacy at which her Yaz prescriptions were filled.
“The plaintiff fact sheet deficiencies identified by the defendants raise questions about the credibility of the information that has been obtained.
“The Court cannot achieve its goals if either side feels that information gathered during the discovery process lacks credibility.”

Judge Herndon, who is presiding over nearly 6,400 suits from federal courts across the country continued, “that the depositions would restore confidence in the process “and may ultimately serve as a catalyst for the just and efficient resolution of this litigation.”’ The Madison Record has reported. disclaimer: This article: Judge Allows Bayer To Depose First 100 Plaintiffs In Yaz, Yasmin, Ocella MDL was posted on Friday, July 29th, 2011 at 7:11 pm at and is filed under Defective Drug Lawsuits.

« »

Leave a Reply

You must be logged in to post a comment.